Related Experiment Video
Updated: Oct 6, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
Manabu Murakami1, Agnieszka M Murakami2, Takayuki Nemoto1
1Department of Pharmacology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Abstract:
Polycystic kidney disease (PKD) is the most common genetic cause of kidney failure in humans. Among the various PKD-related molecules, PKD2L1 forms cation channels, but its physiological importance is obscure. In the present study, we established a transgenic mouse line by overexpressing the dominant-negative form of the mouse PKD2L1 gene (i.e., lacking the pore-forming domain). The resulting PKD2L1del-Tg mice exhibited supraventricular premature contraction, as well as enhanced sensitivity to β-adrenergic stimulation and unstable R-R intervals in electrocardiography. During spontaneous atrial contraction, PKD2L1del-Tg atria showed enhanced sensitivity to isoproterenol, norepinephrine, and epinephrine. Action potential recording revealed a shortened action potential duration in PKD2L1del-Tg atria in response to isoproterenol. These findings indicated increased adrenergic sensitivity in PKD2L1del-Tg mice, suggesting that PKD2L1 is involved in sympathetic regulation.
Insights
Polycystic kidney disease (PKD) protein PKD2L1 influences heart function. Overexpressing a dominant-negative PKD2L1 in mice increased their sensitivity to adrenergic stimulation, impacting heart rhythm.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Genetics
Background:
- Polycystic kidney disease (PKD) is a leading genetic cause of kidney failure.
- PKD2L1, a PKD-related molecule, forms cation channels, but its physiological role remains unclear.
- Understanding PKD2L1's function is crucial for PKD research.
Purpose of the Study:
- To investigate the physiological role of PKD2L1 in cardiac function.
- To determine the impact of dominant-negative PKD2L1 overexpression on adrenergic sensitivity and heart rhythm.
Main Methods:
- Generation of a transgenic mouse model overexpressing a dominant-negative PKD2L1 (PKD2L1del-Tg).
- Electrocardiography to assess heart rhythm and supraventricular premature contractions.
- Pharmacological challenge with adrenergic agonists (isoproterenol, norepinephrine, epinephrine) to evaluate cardiac response.
- Action potential recordings in atrial tissue.
Main Results:
- PKD2L1del-Tg mice displayed supraventricular premature contractions and unstable R-R intervals.
- Atria from PKD2L1del-Tg mice showed heightened sensitivity to adrenergic stimulation.
- Isoproterenol challenge resulted in a shortened action potential duration in PKD2L1del-Tg atria.
Conclusions:
- Overexpression of dominant-negative PKD2L1 leads to increased adrenergic sensitivity in the heart.
- These findings suggest a role for PKD2L1 in sympathetic regulation of cardiac function.
- PKD2L1 may be a potential target for modulating cardiac adrenergic responses.
More Related Videos
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Antihypertensive Drugs: Action of β1 Blockers
GPCR Desensitization
Adrenergic Antagonists: ɑ and β-Receptor Blockers
GPCRs Regulate Adenylyl Cylase Activity
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...

